Argent Biopharma Ltd Cash Flow Reinvestment Rate

Latest as of June 2006: 0.00x

Argent Biopharma Ltd cash flow reinvestment rate. Argent Biopharma Ltd (RGT) has a Cash Flow Reinvestment Rate of 0.00x as of June 2006, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$61.70K. Explore RGT debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

AU$0.00
Capex + Investments

Operating Cash Flow

AU$61.70K
AUD

Capital Expenditures

AU$0.00
AUD

Cash Flow Reinvestment Rate of Argent Biopharma Ltd (2006–2006)

Cash flow reinvestment rate of Argent Biopharma Ltd from 2006 to 2006. Historical reinvestment intensity for Argent Biopharma Ltd across 1 annual periods. Also explore RGT year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Argent Biopharma Ltd Cash Flow Reinvestment Rate by Year (2006–2006)

Argent Biopharma Ltd cash flow reinvestment rate by year from 2006 to 2006. Year-by-year capital reinvestment analysis for Argent Biopharma Ltd. For the full cash flow conversion analysis, see RGT cash flow metrics.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2006 0.00x AU$0.00 AU$41.00K AU$0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow